Advertisement

Topics

Latest "Showcase Your Company Investor Forum" News Stories

13:45 EDT 17th July 2018 | BioPortfolio

Here are the most relevant search results for "Showcase Your Company Investor Forum" found in our extensive news archives from over 250 global news sources.

More Information about Showcase Your Company Investor Forum on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Showcase Your Company Investor Forum for you to read. Along with our medical data and news we also list Showcase Your Company Investor Forum Clinical Trials, which are updated daily. BioPortfolio also has a large database of Showcase Your Company Investor Forum Companies for you to search.

Showing "Showcase Your Company Investor Forum" News Articles 1–25 of 23,000+

Tuesday 17th July 2018

First Wave Brings on Ken Rutt as Strategic Consultant

  Expertise Supports Development of the CLARITY-IA™ Respirator July 17, 2018 – Batavia, New York – Medical Conservation Device, a subsidiary of First Wave Technologies, Inc. (“First Wave” and “company”), announces that the company has engaged the consulting services of Ken Rutt, a senior level mechanical engineer and project engineer with o...


EOS imaging And Fosun Pharmaceutical AG Enter into an Agreement for a Significant Equity Investment

Regulatory News: EOS imaging (Paris:EOSI) (Euronext, FR0011191766 - EOSI), the pioneer of orthopedic medical imaging 2D / 3D, today announced that it entered into a binding agreement with Fosun Pharmaceutical AG, an indirect subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharma, stock code: 600196.SH, 02196.HK), related to an...

EOS imaging Announces First Half 2018 Sales of €17.5 Million Supported by Strong Growth in Asia-Pacific and North America

Regulatory News: EOS imaging (Paris:EOSI) (Euronext, FR0011191766 - EOSI - Eligible PEA - SME), the pioneer of orthopedic medical imaging, 2D/3D, today announced its non-audited consolidated sales revenue for the six months ended June 30, 2018. +11% sales growth over first half 2017 excluding forex impact1, driven by 36%...


Quality Systems, Inc. to Host Fiscal 2019 First Quarter Results Conference Call

Quality Systems, Inc. (NASDAQ: QSII), known to its clients as NextGen Healthcare, will release its fiscal 2019 first quarter ended June 30, 2018 operating results on Tuesday, July 31, 2018 after market close, with a conference call to follow at 5:00 p.m. Eastern Time. Shareholders and interested participants may listen to a live broadcast of the c...

Venture Verde and the Chicago Mushroom Company to Open a Controlled Environment Agricultural Facility in Chicago

Facility to Help Drive New Sustainability Standards for Indoor Urban Farming Venture Verde, a real estate, land and water management company focused on driving sustainability, announced it signed an agreement with the

One of Nation’s Largest Home-Based Care Providers to Rebrand as “Elara Caring”

Following the Combination of Great Lakes Caring, National Home Health Care, and Jordan Health Services, Unified Company Adopts New Name and Branding Today, the newly formed company that combines Great Lakes Caring, National Home Health Care, and Jordan Health Services announced it will be named Elara Caring. In April, these three award-winning health c...

Oxford Immunotec Schedules Second Quarter 2018 Earnings Release and Conference Call for July 31, 2018

OXFORD, United Kingdom and MARLBOROUGH, Mass., July 17, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that it plans to release second quarter 2018 financial results prior to market open on Tuesday, July 31, 2018. Dr. Peter Wrighton-Smith, Chief Executive Officer, and Rick Altieri, Chief Financial Officer, will h...

HMP's 8th Annual Amputation Prevention Symposium Expected to Draw 800 Clinicians to Chicago to Join the CLI Revolution

Multidisciplinary gathering will provide practical education on the treatment and prevention of critical limb ischemia (CLI) MALVERN, Pa. (PRWEB) July 17, 2018 HMP, a leading healthcare events and education company, today announced the 8th Annual Amputation Prevention Symposium (AMP) will take place August 8-11, 2018 in Chicago. Led by Jihad A. Mustapha, MD, FACC, FSCAI, a pioneer in the field of...

Independent/Provider-Sponsored Administrative Costs Accelerated in 2017

Independent/Provider-Sponsored health plans had administrative cost increases of 5.5% in 2017, the highest since 2013. Last year’s increase was 2.4%. Increases are calculated for continuously participating plans, after backing out the effect of mix changes. On an as-reported basis, per member costs grew by 5.2% compared with 3.0% in the prior ye...

Global Medical REIT Inc. Schedules 2018 Second Quarter Financial Results Conference Call

Conference Call Scheduled for Wednesday, August 8, 2018 at 9:00 a.m. ET Global Medical REIT Inc. (NYSE:GMRE) (the “Company”), a Maryland corporation engaged primarily in the acquisition of licensed, state-of-the-art, purpose-built healthcare facilities and the leasing of these facilities to strong clinical operators with leading market share, ...

Teva Highlights Key Milestones Achieved in the 2017 Social Impact Report

Today, Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) published its annual social impact report, highlighting achievements related to the two pillars that drive the Company’s initiatives: building healthy communities and leading a responsible business. Teva’s 2017 Social Impact Report spotlights the company’s commitment to corpora...

Dr. Karen Cox Named President of Chamberlain University

Dr. Susan Groenwald becomes President Emeritus Adtalem Global Education (NYSE: ATGE) today announced Dr. Karen Cox, PhD, RN, FACHE, FAAN, as the new President of Chamberlain University, and she will begin her leadership on August 27, 2018. Dr. Cox is a highly accomplished nursing and healthcare leader, who most recently served as Executive Vice Preside...

STADA Arzneimittel AG: Voting results of the bondholders' meeting on July 17, 2018 concerning the STADA-Bond 2015/2022: Appointment of One Square Advisory Services GmbH as joint representative and adjournment of the further agenda items

DGAP-News: STADA Arzneimittel AG / Key word(s): Bond/Miscellaneous 17.07.2018 / 12:05 The issuer is solely responsible for the content of this announcement. Bad Vilbel, July 17, 2018 - STADA Arzneimittel Aktiengesellschaft ("STADA" or the "Issuer") hereby announces the voting results of the meeting on July 17, 2018 (the "Bondholders' Meeting") of the bondholders (the "Bondholders ") of ...

American Shared Hospital Services Selects PCG Advisory Group for Investor Relations and Strategic Communications

American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, today announced that it has retained PCG Advisory Group, a leading investor relations and digital strategies firm, to serve as an advisor for investor relations and strategic c...

Jamieson Wellness Inc. Announces Date of Second Quarter 2018 Financial Results and Conference Call

Jamieson Wellness Inc. ("Jamieson Wellness" or the "Company") (TSX:JWEL) announced today that the Company will release its second quarter 2018 financial results after the market close on Wednesday, August 8, 2018. The Company will host a conference call for investors at 5:00 p.m. Eastern Time to discuss the second quarter 2018 results. The call ca...

TripleCare Brings Physician-Based Telemedicine Services to Commonwealth Care of Roanoke

Services to Roll out in all 12 Commonwealth Care Locations; Three Initially in the 2018 Third Quarter with Nine to be Completed by Year-end TripleCare, a national provider of telemedicine-based healthcare to the post-acute care sector, including skilled nursing facilities (SNFs), announced today the Company will introduce its services across all

Sunovion to Launch Take On Tomorrow™ Giving Opportunity with Red Sox Foundation and 7th Annual Community Service Program

Expecting to Reach 25,000 Cumulative Employee Volunteer Hours This Summer, Company Will Mark Milestone by Donating $25,000 to Support Education and Mental Health Initiatives Sunovion Pharmaceuticals Inc. (Sunovion), a partner of the Boston Red Sox, today announced that the Company is continuing its a

22nd Century Announces the Immediate Feasibility of the FDA’s Nicotine Reduction Plan

Reynolds American and Phillip Morris unable to comply with the FDA’s plan “for 20-years” 22nd Century Group, Inc. (NYSE American:XXII), a plant biotechnology company that is a leader in tobacco harm reduction and Very Low Nicotine tobacco, yesterday responded to the Advance Notice of Proposed Rulemaking (

Can-Fite Granted Australian and Chinese Patents for Erectile Dysfunction Drug

Erectile dysfunction market is estimated to reach $3.2 billion by 2022 Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address liver diseases, inflammatory diseases and sexual dysfunction, today announced that the Australian and Chinese patent offices have ...

Co-Diagnostics Completes Submission of CE Mark Registration for Tuberculosis Screening Test

Company’s Logix Smart™ MTB Test to be available for purchase with CE mark in August 2018 Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, proprietary platform for the development of molecular diagnostic tests, announced today that its Logix Smart™ MTB Test technical file has been submitted for registra...

MOLOGEN AG: Resolved reverse share split implemented

DGAP-News: MOLOGEN AG / Key word(s): Corporate Action 17.07.2018 / 10:16 The issuer is solely responsible for the content of this announcement. Press release No. 15/2018 on 17 July 2018 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNL...

APEIRON Appoints Peter Llewellyn-Davies as Chief Executive Officer

DGAP-News: APEIRON Biologics AG / Key word(s): Change of Personnel 17.07.2018 / 10:00 The issuer is solely responsible for the content of this announcement. APEIRON Appoints Peter Llewellyn-Davies as Chief Executive Officer The former CEO Dr. Hans Loibner will continue to support the Company as senior advisor Vienna, Austria, 17 July 2018: APEIRON Biologics AG, a company focused on ca...

Innovus Pharmaceuticals Reports Preliminary Q2 2018 Sales Revenue of $6.6 million to $6.8 million

Preliminary Quarterly Revenue Increase of 47-51% and Comparable 2017 Second Quarter Increase of 330-340% and Fiscal Year 2018 Net Revenue Annual Guidance Adjusted Upwards to at Least $22 Million Innovus Pharmaceuticals, Inc., (“Innovus Pharma”) (OTCQB: INNV), today announced preliminary second quarter 2018 net revenue is estimated to be between $6....

H.I.G. Capital Signs Definitive Agreement for the Sale of AMPAC Fine Chemicals

H.I.G. Capital (“H.I.G.”), a leading global private equity investment firm with more than $25 billion of equity capital under management, is pleased to announce the signing of a definitive agreement for the sale of its portfolio company AMPAC Fine Chemicals (“AFC” or the “Company”) to SK Holdings Co. Ltd. Based in Rancho Cordova, CA, A...

Update on Progress of Broad Spectrum Antibiotic RECCE®327 Towards Clinical Trials

SYDNEY, Australia - 17 July 2018 - Recce Pharmaceuticals Ltd (ASX:RCE) (Company), the Company developing a new class of synthetic, broad spectrum antibiotics, today provided an update on its progress towards the start of human trials of its lead compound RECCE®327, for the treatment of sepsis, including a simple clinical trial design. RECCE®327 is being developed as a new class of a...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks